BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS

Go back to BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS

Bio-Techne Corp. (TECH) PT Lowered to $500 at Stifel

August 4, 2022 3:52 PM UTC

Stifel analyst Daniel Arias lowered the price target on Bio-Techne Corp. (NASDAQ: TECH) to $500.00 (from $560.00) while maintaining a Buy rating following results.

The analyst commented, "TECH's finish to fiscal 2022 was solid, and marked by 14% organic that brought FY22 to 16%. Looking to FY23, mgmt's... More

Bio-Techne (TECH) Misses Q4 EPS by 3c

August 4, 2022 6:42 AM UTC

Bio-Techne (NASDAQ: TECH) reported Q4 EPS of $2.05, $0.03 worse than the analyst estimate of $2.08. Revenue for the quarter came in at $288.2 million versus the consensus estimate of $287.12 million.

For earnings history and earnings-related data on Bio-Techne (TECH) click here.

... More